Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand

Emily Bain; Tanya Bubner; Pat Ashwood; Caroline A. Crowther; Philippa Middleton

doi:10.1111/ajo.12008

Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand

Emily Bain, Tanya Bubner, Pat Ashwood, Caroline A. Crowther, Philippa Middleton

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent of respondents reported that their hospital is currently following a guideline; 36% confirmed that their hospital is auditing uptake. Estimates of uptake ranged from 53 to 90%. Ongoing education and support are needed to ensure that the guidelines are optimally implemented, and uptake and important health outcomes are monitored.

Original language	English
Pages (from-to)	86-89
Number of pages	4
Journal	Australian and New Zealand Journal of Obstetrics and Gynaecology
Volume	53
Issue number	1
DOIs	https://doi.org/10.1111/ajo.12008
Publication status	Published or Issued - Feb 2013
Externally published	Yes

Keywords

antenatal care
clinical practice
guidelines
magnesium sulphate
preterm
survey

ASJC Scopus subject areas

Obstetrics and Gynaecology

Access to Document

10.1111/ajo.12008

Cite this

@article{12a1851f8b4b43b4aab0102ba50bb36b,

title = "Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand",

abstract = "Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent of respondents reported that their hospital is currently following a guideline; 36% confirmed that their hospital is auditing uptake. Estimates of uptake ranged from 53 to 90%. Ongoing education and support are needed to ensure that the guidelines are optimally implemented, and uptake and important health outcomes are monitored.",

keywords = "antenatal care, clinical practice, guidelines, magnesium sulphate, preterm, survey",

author = "Emily Bain and Tanya Bubner and Pat Ashwood and Crowther, {Caroline A.} and Philippa Middleton",

year = "2013",

month = feb,

doi = "10.1111/ajo.12008",

language = "English",

volume = "53",

pages = "86--89",

journal = "Australian and New Zealand Journal of Obstetrics and Gynaecology",

issn = "0004-8666",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand

AU - Bain, Emily

AU - Bubner, Tanya

AU - Ashwood, Pat

AU - Crowther, Caroline A.

AU - Middleton, Philippa

PY - 2013/2

Y1 - 2013/2

N2 - Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent of respondents reported that their hospital is currently following a guideline; 36% confirmed that their hospital is auditing uptake. Estimates of uptake ranged from 53 to 90%. Ongoing education and support are needed to ensure that the guidelines are optimally implemented, and uptake and important health outcomes are monitored.

AB - Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent of respondents reported that their hospital is currently following a guideline; 36% confirmed that their hospital is auditing uptake. Estimates of uptake ranged from 53 to 90%. Ongoing education and support are needed to ensure that the guidelines are optimally implemented, and uptake and important health outcomes are monitored.

KW - antenatal care

KW - clinical practice

KW - guidelines

KW - magnesium sulphate

KW - preterm

KW - survey

UR - http://www.scopus.com/inward/record.url?scp=84874108521&partnerID=8YFLogxK

U2 - 10.1111/ajo.12008

DO - 10.1111/ajo.12008

M3 - Article

C2 - 23106226

AN - SCOPUS:84874108521

SN - 0004-8666

VL - 53

SP - 86

EP - 89

JO - Australian and New Zealand Journal of Obstetrics and Gynaecology

JF - Australian and New Zealand Journal of Obstetrics and Gynaecology

IS - 1

ER -

Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this